BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11181205)

  • 21. Peak inspiratory flow through diskus and turbuhaler, measured by means of a peak inspiratory flow meter (In-Check DIAL).
    van der Palen J
    Respir Med; 2003 Mar; 97(3):285-9. PubMed ID: 12645837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced Peak Inspiratory Effort through the Diskus((R)) and the Turbuhaler((R)) due to Mishandling is Common in Clinical Practice.
    Melani AS; Bracci LS; Rossi M
    Clin Drug Investig; 2005; 25(8):543-9. PubMed ID: 17532698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peak inspiratory flow rates generated through the Novolizer and the Turbuhaler dry powder inhaler devices by children with stable asthma.
    von Berg A; Kremer HJ; Ellers-Lenz B; Conrad F; Erb K; Maus J; Hermann R
    J Aerosol Med; 2007; 20(1):50-8. PubMed ID: 17388753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inspiratory muscle training may increase peak inspiratory flow in chronic obstructive pulmonary disease.
    Weiner P; Weiner M
    Respiration; 2006; 73(2):151-6. PubMed ID: 16155355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peak inspiratory flow through Turbuhaler in chronic obstructive airways disease.
    Dewar MH; Jamieson A; McLean A; Crompton GK
    Respir Med; 1999 May; 93(5):342-4. PubMed ID: 10464901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The relationships between the peak inspiratory flow and the characteristics factors in the asthmatics with inhaled corticosteroid -a multicenter study in Chugoku Shikoku area].
    Obase Y; Kanehiro A; Tanimoto Y; Miyahara N; Oka M; Eda R; Kubota T; Yokoyama A; Wakabayashi K; Takeyama H; Okada C; Kimura G; Soda R; Takahashi K; Tanimoto M
    Arerugi; 2011 Dec; 60(12):1621-9. PubMed ID: 22343777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Usefulness of peak expiratory flow measurement for selection of dry powder inhalers in asthmatic children].
    Emeryk A; Bartkowiak-Emeryk M; Czerwińska-Pawluk I; Postepski J
    Pol Merkur Lekarski; 2000 Oct; 9(52):667-70. PubMed ID: 11144053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Maximum inspiratory flows in healthy children and asthmatics 4 to 8 years old. The implications for the inhalation of drugs in powder form].
    Aguilar Miranda P; Mallol Villablanca J
    Arch Bronconeumol; 2000 Feb; 36(2):73-6. PubMed ID: 10726194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can patients achieve sufficient peak inspiratory flow rate (PIFR) with Turbuhaler® during acute exacerbation of asthma?
    Mohd Rhazi NA; Muneswarao J; Abdul Aziz F; Ibrahim B; Kamalludin A; Soelar SA
    J Asthma; 2023 Aug; 60(8):1608-1612. PubMed ID: 36650693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of inspiratory flow-volume curves in children with bronchial asthma and patients with cystic fibrosis].
    Holmann JC; Schibler A; Kraemer R
    Schweiz Med Wochenschr; 1989 Dec; 119(48):1713-8. PubMed ID: 2617276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventolin Diskus and Inspyril Turbuhaler: an in vitro comparison.
    Broeders ME; Molema J; Burnell PK; Folgering HT
    J Aerosol Med; 2005; 18(1):74-82. PubMed ID: 15741776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new breath actuated dry powder inhaler (Auto-Jethaler)].
    Steiss JO; Heckmann M; Jödicke B; Landmann E; Schüler D; Weber K; Pabst J; Lindemann H
    Klin Padiatr; 2007; 219(2):66-9. PubMed ID: 16878285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction.
    Broeders ME; Molema J; Hop WC; Folgering HT
    J Aerosol Med; 2003; 16(2):131-41. PubMed ID: 12823907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhalation characteristics of patients when they use different dry powder inhalers.
    Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs).
    Terzano C; Oriolo F
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of inspiratory flow-volume curve].
    Narushima M; Tomita S; Tsuzura Y; Kasai T; Endo S; Kaneko N; Yamada M; Ohtsuka H; Akizawa T; Suzuki H
    Arerugi; 1998 May; 47(5):493-9. PubMed ID: 9656570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Usefulness of breath actuated devices in asthmatic children with bronchial obstruction].
    Tomalak W; Doniec Z
    Wiad Lek; 2006; 59(1-2):61-5. PubMed ID: 16646295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler.
    Serra-Batlles J; Plaza V; Badiola C; Morejón E;
    J Aerosol Med; 2002; 15(1):59-64. PubMed ID: 12006146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older.
    Tiddens HA; Geller DE; Challoner P; Speirs RJ; Kesser KC; Overbeek SE; Humble D; Shrewsbury SB; Standaert TA
    J Aerosol Med; 2006; 19(4):456-65. PubMed ID: 17196074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.